Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2022 ,inter alia, to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, August 29,2022, inter alia, to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30, 2022 and to consider recommendation of dividend (if any).
|